{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:50:58Z","timestamp":1777434658324,"version":"3.51.4"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,5]]},"DOI":"10.1093\/neuonc\/noae018","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T23:19:45Z","timestamp":1706656785000},"page":"623-624","source":"Crossref","is-referenced-by-count":2,"title":["Targeted therapy done right: Direct sonic hedgehog inhibition for sonic hedgehog medulloblastoma"],"prefix":"10.1093","volume":"26","author":[{"given":"Anandani","family":"Nellan","sequence":"first","affiliation":[{"name":"Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland , USA"},{"name":"Surgical Neurology Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6700-5621","authenticated-orcid":false,"given":"Sadhana","family":"Jackson","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"issue":"4","key":"2024040505535759700_CIT0001","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11864-014-0306-4","article-title":"Management of pediatric and adult patients with medulloblastoma","volume":"15","author":"Martin","year":"2014","journal-title":"Curr Treat Options Oncol."},{"issue":"24","key":"2024040505535759700_CIT0002","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1200\/JCO.2014.60.1591","article-title":"Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase ii pediatric brain tumor consortium studies PBTC-025B and PBTC-032","volume":"33","author":"Robinson","year":"2015","journal-title":"J Clin Oncol."},{"issue":"41","key":"2024040505535759700_CIT0003","doi-asserted-by":"crossref","first-page":"69295","DOI":"10.18632\/oncotarget.20619","article-title":"Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor","volume":"8","author":"Robinson","year":"2017","journal-title":"Oncotarget."},{"issue":"4","key":"2024040505535759700_CIT0004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/neuonc\/noad191","article-title":"Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects","volume":"26","author":"Kresbach","year":"2024","journal-title":"Neuro-Oncol"},{"issue":"13","key":"2024040505535759700_CIT0005","doi-asserted-by":"crossref","first-page":"108917","DOI":"10.1016\/j.celrep.2021.108917","article-title":"Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality","volume":"34","author":"Dang","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"2024040505535759700_CIT0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1593\/neo.81264","article-title":"Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2\/BCRP and ABCB1\/Pgp","volume":"11","author":"Zhang","year":"2009","journal-title":"Neoplasia"},{"key":"2024040505535759700_CIT0007","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yrtph.2017.12.015","article-title":"Carcinogenicity assessment of the Hedgehog pathway inhibitor, vismodegib in Tg.rasH2 mice and Sprague-Dawley rats","volume":"92","author":"Li","year":"2018","journal-title":"Regul Toxicol Pharmacol."},{"issue":"1","key":"2024040505535759700_CIT0008","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12885-017-3286-5","article-title":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","volume":"17","author":"Sekulic","year":"2017","journal-title":"BMC Cancer."},{"issue":"9","key":"2024040505535759700_CIT0009","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s13555-023-00989-x","article-title":"Recommendations for cost-conscious treatment of basal cell carcinoma","volume":"13","author":"Patel","year":"2023","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noae018\/56779080\/noae018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/4\/623\/57158568\/noae018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/4\/623\/57158568\/noae018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:54:06Z","timestamp":1731131646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/4\/623\/7593666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1,30]]},"published-print":{"date-parts":[[2024,4,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noae018","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,1,30]]}}}